Retinopathy and Diabetic Macular Edema: innovative diagnostic-therapeutic directions, including integrated management and patient centrality
16 July 2018
Naples, 16 July 2018
09:30 to 16:30
Sala Posillipo, Eurostars Hotel Excelsior
Via Partenope, 48, 80121 Naples ITALY
Diabetic Macular Edema (EMD) is a degenerative ocular disease related to diabetes, severely disabling because of the progressive reduction of sight often leading to blindness.
The meeting aims to stimulate debate among all players, at a clinical and procedural level, with great focus on the patient's real needs, in terms of innovative therapeutic solutions and quality of life, in order to identify shared and functional diagnostic-therapeutic directions.
In this sense, within the scope of the works, ample space will be reserved for specific economic-health assessments, supported by evidence related to the social costs of the disease, allowing to highlight the real benefits of a timely diagnosis and the best integrated management of the patient .
The round table will give ample space to patients, specialists and experts of the field, to further develop relevant issues that will emerge during the morning session, as well as addressing all systemic issues and assessing possible local best practices.
Prof. Francesco Rossi, Professor of Pharmacology, "Luigi Vanvitelli" University of Campania
Prof. Francesca Simonelli, Professor of Ophthalmology, University of Campania "Luigi Vanvitelli" and Head of the Center for Hereditary Retinopathies, President of the Italian Society of Ophthalmology Genetics
click here to view the updated program
"The only thing worse than being blind is having sight but no vision."